Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
LIV-1 mAb - 01 | PCC | Solid Tumor | Colorectal cancer,Breast cancer |
Anti-LIV-1 mAb captured on CM5 chip via anti-human IgG Fc antibody can bind Human LIV-1, His Tag (Cat. No. LV1-H5223) with an affinity constant of 5.24 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Ladiratuzumab vedotin | SGN-LIV1A; MK-6440; MK6440 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Esophageal Squamous Cell Carcinoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
BRY-812 | BRY-812 | Phase 1 Clinical | BioRay Pharmaceutical Co Ltd | Solid tumours; Neoplasms | Details |
Ladiratuzumab vedotin | SGN-LIV1A; MK-6440; MK6440 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Esophageal Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Prostatic Neoplasms; Breast Neoplasms; Esophageal Squamous Cell Carcinoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
BRY-812 | BRY-812 | Phase 1 Clinical | BioRay Pharmaceutical Co Ltd | Solid tumours; Neoplasms | Details |
This web search service is supported by Google Inc.